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Background: Patients with borderline acetabular dysplasia are a controversial patient population in hip preservation, as some
have primarily impingement-based symptoms and others have instability-based symptoms. Borderline dysplasia is most commonly defined as a lateral center-edge angle (LCEA) of 20 to 25 . However, its prevalence has not been well established in the
literature.
Purpose: To (1) define the prevalence of borderline hip dysplasia in the general population as well as in populations presenting with
hip pain using a systematic review and meta-analysis of the literature and (2) describe differences between male and female
patients as well as differences in prevalence from that of classic acetabular dysplasia.
Study Design: Systematic review; Level of evidence, 3.
Methods: A systematic review of the literature was performed using search terms to capture borderline dysplasia, or studies
reporting prevalence by LCEA. The search yielded 1932 results, of which 11 articles met inclusion criteria and were included in the
final systematic review. Studies were grouped by patient cohort as (1) asymptomatic general population, (2) asymptomatic targeted population (eg, athletes in a specific sport), and (3) symptomatic hip pain population. The reporting of prevalence rates by
subject or by hip was recorded. In a study, the rates of borderline dysplasia were compared with those of classic acetabular
dysplasia (LCEA, <20 ).
Results: The 11 studies included 19,648 hips (11,754 patients). In the asymptomatic general population, the pooled estimate of the
prevalence of borderline dysplasia was 19.8% by subject and 23.3% by hip (range, 16.7%-46.0%). The targeted subpopulation
group included 236 athletes with subgroups in ballet, football, hockey, volleyball, soccer, and track and field with prevalence
ranging from 17.8% to 51.1%. The prevalence of borderline dysplasia in groups presenting with hip pain was 12.8% (range,
12.6%-16.0%). Borderline acetabular dysplasia was 3.5 times more common than classic acetabular dysplasia in the asymptomatic general population.
Conclusion: This study demonstrated a prevalence of borderline dysplasia of 19.8% to 23.3% in the asymptomatic general
population. Additionally, an estimated prevalence of 12.8% of hips in symptomatic patients highlights the common decisionmaking challenges in this population.
Keywords: borderline hip dysplasia, acetabular dysplasia, prevalence

<20 , borderline acetabular dysplasia is most commonly
defined as an LCEA of 20 to 25 , and some authors define
it as an LCEA of 18 to 25 .8,50 Some patients in this population have primarily impingement-based symptoms, while
other patients have primarily instability-based symptoms.‡
No current gold standard exists for differentiating these
subgroups. No direct comparative studies exist comparing
these primary treatment approaches (isolated hip

Borderline acetabular dysplasia is a controversial topic in
hip preservation surgery because of the limited evidence to
guide decision making between surgical treatment options
in this transitional morphology between instability and
impingement. While classic acetabular dysplasia is most
commonly defined as a lateral center-edge angle (LCEA)
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arthroscopy vs periacetabular osteotomy [PAO] with or
without arthroscopy). The outcomes of these procedures
in this population have been good in selected subgroups,
but a subset of patients appears to have suboptimal outcomes (up to 30% in some series).12,37
The risk of osteoarthritis (OA) has been well
established in classic acetabular dysplasia (LCEA,
<20 )§ but has been demonstrated to extend into the
borderline subgroup as well.53 Thomas et al52 reported
a linear risk increase for each degree of LCEA <28 . This
means that patients with borderline dysplasia may have
an increased risk of OA compared with those with normal LCEA, but this risk is less than that of classic acetabular dysplasia. Borderline acetabular dysplasia can
cause OA due to chronic joint instability leading to chondral surface overload, which can produce irreversible
articular cartilage and labral damage, thereby reducing
the longevity of the hip joint.6,7 Many hips with borderline dysplasia have cam-type morphologies of the proximal femur that may lead to femoroacetabular
impingement (FAI), which is also well established as a
risk factor for hip OA.1,2,5,21,39,48,49
Decision making in the setting of borderline dysplasia is
a common clinical dilemma. The clinical presentation of
borderline hip dysplasia is similar to that of other young
adult hip disorders such as FAI or classic acetabular dysplasia.43 Diagnosis begins with a clinical history, physical
examination, and radiographic imaging.35,40 No agreedupon current clinical criteria for differentiating impingement and instability in this population exist as multiple
factors (femoral and acetabular hip morphology, soft tissue
laxity, apprehension testing, range of motion) contribute to
an accurate diagnosis in these cases. Different radiographic
measurements are used to assess acetabular dysplasia such
as the LCEA, anterior center-edge angle, and Tönnis angle/
acetabular inclination.4,7,9,10,30,38
An important initial step to understanding a condition
is to establish its prevalence.17,45 The prevalence of borderline acetabular dysplasia is currently not well
established in the literature. The purpose of this study
was to estimate the prevalence of borderline hip dysplasia in the general population, as well as in groups of
patients presenting with hip pain. Additionally, we
described differences in rates between male and female
patients and compared the prevalence with that of classic acetabular dysplasia.

§
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METHODS
A systematic review was conducted according to the
PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) guidelines. The following
question was posed: “What is the prevalence of borderline
acetabular dysplasia in hips with and without hip pain?”
The published literature was searched using strategies created by an independent medical librarian for measurements of the LCEA in the hip or borderline hip dysplasia.
The search strategies were established using a combination
of standardized terms and keywords and were implemented in Ovid Medline (1946-2020), Embase (1947-2020),
Cochrane Central Register of Controlled Trials, Cochrane
Database of Systematic Reviews, and ClinicalTrials.gov.
Full-search strategies are provided in Appendix Table A1.
The reference lists of each study that met the eligibility
criteria were also reviewed to identify other relevant studies. All searches were completed in February 2020.
There were a total of 1932 results, with 1166 unique
results after duplicates were removed. A total of 11 studiesk
met the inclusion criteria and were included in the final
systematic review (Figure 1).

Eligibility Criteria
Studies were considered eligible if they reported prevalence
of borderline acetabular dysplasia in their study cohorts.
Only manuscripts written in English were considered, and
only cohorts with patients aged 12 years were included.
Exclusion criteria included nonhuman subjects, cadaveric
studies, abstracts or unpublished works, imaging technique studies, surgical technique studies, reviews and
meta-analyses, case reports, other hip disorders (trauma,
avascular necrosis, connective tissue disorders, or other
preexisting orthopaedic conditions, soft tissue and joint
conditions [eg, slipped capital femoral epiphysis, LeggCalve-Perthes]), or studies that did not report prevalence
of borderline acetabular dysplasia.

Data Collection
Two blinded reviewers (S.F., L.F.) independently assessed
each study title, abstract, and full text, as applicable.. The
following variables were extracted from the selected articles: date of study, study type, study country, level of evidence, sex, age, total number of hips in cohort, number of
hips with borderline acetabular dysplasia, number of hips
k
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analysis.44 A random-effects meta-analysis was performed
to account for heterogeneity between studies. Confidence
intervals were calculated using exact binomial
distribution.42

Records identified through
database searching
(n = 1932)

Records screened
(n = 1166)
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· Abstract only (63)
· Age (102)
· Cadaveric/nonhuman (52)
· Other hip disorders (234)
· Study type (176)
· Language (76)
· Not borderline (333)

Excluded (n = 119)
· Study type (5)
· Not borderline or did not
report prevalence (114)

Studies included in
qualitative synthesis
(n = 11)

Studies included in
quantitative synthesis
(n = 11)

Figure 1. PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) study flow diagram.
with classic acetabular dysplasia, and radiographic definition used to diagnose borderline acetabular dysplasia as
well as classic acetabular dysplasia. For 2 included studies,33,48 prevalence was extracted from figures in the published text, as it was not explicitly stated in the manuscript.
The definition of borderline acetabular dysplasia for all
papers was an LCEA of 20 to 25 .

Statistical Analysis
Prevalence of borderline acetabular dysplasia (as well as
classic acetabular dysplasia) was broken down into subgroups for further analysis. Studies were grouped by
patient cohort as (1) asymptomatic general population, (2)
asymptomatic targeted population (such as athletes in a
specific sport), and (3) symptomatic hip general population.
The reporting of prevalence rates of borderline dysplasia in
each study was characterized by subject or by hip. When
reported, the prevalence specific to male and female subject
was abstracted. Finally, rates of borderline dysplasia were
compared with those of classic acetabular dysplasia (LCEA,
<20 ) in each of these groups.
Statistical analyses were performed to define prevalence
estimates and associated 95% confidence intervals for borderline dysplasia in the different populations. A metaanalysis was performed using Stata with metaprop

The 11 included studies comprised a total of 19,648 hips in
11,754 subjects. There were 4 level 2 studies16,22,26,47 and 7
level 3 studies.7,20,27,28,31,33,36

General Population Subgroup
The general population subgroup included 4 studies of 7595
subjects (15,190 hips) with an average age of 40.6 years and
60.2% women (5175 patients) (Table 1). The estimated prevalence of borderline acetabular dysplasia in the general
population subgroup was 23.3% by hip and 19.8% by patient
(range, 16.7%-46.0%) (Figure 2). In the largest included
study, Jacobsen et al23 reported on a prospective longitudinal cohort study of 3859 asymptomatic subject (7718 hips)
from the Copenhagen City Heart Study.22,23 Overall, 63.0%
of the subjects were women, and the cohort had an average
age of 61 years. In this study, 19.2% of hips (by hip) were
classified as borderline dysplasia, and 3.4% of hips were
classified as classic acetabular dysplasia. Engesæter et al16
reported on a prospective population-based cohort of 2072
asymptomatic 19-year-old Norwegians (4144 hips), with
57.8% of the subjects being women. Overall, 16.7% of the
participants were borderline dysplastic, and 3.3% had acetabular dysplasia. Kapron et al27 reported a cross-sectional
study of 63 female athletes (126 hips) participating in
National Collegiate Athletic Association Division I collegiate
volleyball, soccer, or track and field. Given the broad number of sports involved, this was considered to be relatively
representative of the general population. The average age
was 19.6 years in this study. Overall, 46.0% of hips were
borderline dysplastic, and 20.6% of hips had acetabular dysplasia. Raveendran et al47 reported on the Johnston County
Osteoarthritis Project in the United States. This cohort
included 1601 subjects (3202 hips) and allowed calculation
of rates by subject and by hip. In this study, the borderline
dysplasia rate by hip was 18.8%, while the rate by patient
was 25.1% (rate by subject ¼ 1.33 times the rate by hip).

Targeted Population
The targeted population subgroup included 236 athletes
(ballet, football, hockey) (472 hips) from 4 studies (Table
2). This group had an average age of 22.2 years and was
62.3% male, with a pooled prevalence of borderline dysplasia prevalence of 26.4% (range, 10.6%-36.2%). Kapron
et al26 reported on a prospective cohort study of 67 asymptomatic male football players (134 hips) with a prevalence
of borderline dysplasia of 19.4%. Harris et al20 reported a
cross-sectional study of 47 consecutive asymptomatic subjects (94 hips) in an international professional ballet company. The cohort had an average age of 23.8 years, with
55.4% of participants being women. Of the 47 patients,
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TABLE 1
General Population Studies on Borderline Acetabular Dysplasia Prevalence (N ¼ 7595 Patients; 15,190 Hips; 68.1% Women)a

Lead Author
(Year)
Engesæter
(2013)16
Raveendran
(2018)47
Jacobsen
(2005)22
Kapron
(2015)27

Study Type
(LOE)
Prospective
longitudinal
cohort (2)
Prospective
longitudinal
cohort (2)
Prospective
longitudinal
cohort (2)
Cross-sectional
(3)

Population
Invited follow-up of
population-based
cohort; age, 17-20 y
Population-based cohort;
age, >45 y; OA
exclusion
Population-based cohort;
no OA exclusion

Location

Patients
(Hips), n

Age, y

Sex

Definition by
Hip or by
Patient

Norway

2072 (4144) 18.6 (17.3-20.2) 58% female
By patient
(n ¼ 1199)

USA

1601 (3202)

Denmark 3859 (7718)

Female collegiate athletes USA
(volleyball, soccer, and
track and field)

63 (126)

LCEA Definition
of Dysplasia
Radiographic
Technique
Standing AP
pelvis

Borderline Classic
20 -24.9

<20

63 ± 10

57.2% female By patient and Supine AP
(n ¼ 1483)
by hip
pelvis

20 -25

20

61 (22-93)

63% female
By hip
(n ¼ 2430)

Standing AP
pelvis

20 -25

20

100% female

Supine AP
pelvis

20 -25

<20

19.6 ± 1.4

By hip

a
Data are shown as mean (range) or mean ± SD unless otherwise indicated. AP, anteroposterior; LCEA, lateral center-edge angle; LOE,
level of evidence; OA, osteoarthritis.

Figure 2. Meta-analysis of prevalence of borderline acetabular dysplasia. *Study excluded classic acetabular dysplasia. ES, effect
size.
51.1% had borderline dysplasia, and 36.2% had classic acetabular dysplasia. Thus, a total 87.2% of hips in this study
had an LCEA <25 . Larson et al32 reported on a crosssectional study of 59 male National Hockey League athletes
(118 hips) with an average age of 24.2 years. The prevalence of borderline acetabular dysplasia in this cohort was
17.8%. Kapron et al27 was also included in this subanalysis,
as the authors provided a borderline dysplasia prevalence
breakdown for individual sports (soccer 50%, track and
field 43%, volleyball 46%).

Symptomatic Population
There were 4 studies reporting the prevalence of borderline
dysplasia in the symptomatic population (all reported by
hip) (Table 3).20,26,27,33. These studies evaluated a total of

4018 hips with an average age of 36.5 years, with 54.2%
being women (2126 patients). The estimated prevalence of
hips with borderline dysplasia in populations presenting
with hip pain was 12.8% (range, 12.6%-16.0%).
Among these studies, Kraeutler et al31 reported a retrospective comparative study including a series of 341 subjects
(436 hips; mean age, 33.9 years; 74.1% women) presenting
with hip pain to a dedicated hip preservation clinic. The
prevalence of borderline dysplasia and classic acetabular
dysplasia was 14.0% and 11.7%, respectively. Matsuda
et al36 reported a cohort of 1053 subjects undergoing hip
arthroscopy by 7 surgeons. This study only reported prevalence of overall dysplasia (borderline þ classic dysplasia;
LCEA, <25 ) and found a prevalence of 12.6% of hips (133/
1053). However, most patients with classic acetabular dysplasia are generally not considered to be appropriately
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TABLE 2
Targeted Subpopulation Studies on Borderline Acetabular Dysplasia Prevalence (n ¼ 236 Patients; 472 Hips; 62.3% Men)a
LCEA Definition
of Dysplasia
Lead Author
(Year)
Larson
(2017)33
Kapron
(2011)26

Study Type (LOE)

Patients
Location (Hips), n

Population

Cross-sectional (3)

Professional hockey NHL
players
Prospective cohort (2) Collegiate
USA
American
football players
Cross-sectional (3)
Professional ballet
USA

Harris
(2016)20
Kapron
Cross-sectional (3)
(2015)27
(subgroups)

Female collegiate
volleyball
Female collegiate
soccer
Female collegiate
track and field

Definition by Hip Radiographic
Borderline Classic
or by Patient
Technique

Sex

59 (118)

24.2 (18-36)

100% male

By hip

AP pelvis

20 -25

<20

67 (134)

21 ± 1.9

100% male

By hip

Supine AP
pelvis

20 -25

<20

20 -25

<20

20 -25

<20

23.8 ± 5.4 (18-39) 53.3% female
(n ¼ 26)
N/A
100% female

47 (94)

USA

Age, y

22 (44)

By patient and by Standing AP
hip
pelvis
By hip
Supine AP
pelvis

28 (56)
13 (26)

a
Data are shown as mean (range) or mean ± SD (range) unless otherwise indicated. AP, anteroposterior; LCEA, lateral center-edge angle;
LOE, level of evidence; N/A, not available; NHL, National Hockey League.

TABLE 3
Symptomatic Population Studies on Borderline Acetabular Dysplasia Prevalence (n ¼ 4018 Hips; 54.2% Women)a
Lead
Author
(Year)

Study Type
(LOE)

Matsuda
(2018)36
Kaya
(2016)28
Bolia
(2018)7

Retrospective
cohort (3)
Retrospective
cohort (3)
Retrospective
cohort (3)

Kraeutler
(2019)31

Retrospective
cohort (3)

Population
Multicenter, patients
with hip arthroscopy
Patients with hip
arthroscopy patients
Patients with hip
arthroscopy;
excluded patients
with LCEA <20 and
>40
Hip preservation clinic
(included both hips)

Location
USA

Patients,
n
1053

Japan

100

USA

2429

USA

436

Definition by
Hip or by
Patient

Age, y

Sex

32 ± 13.8 for
borderline
47.2 (18-76)

62.7%
female
66% female

By hip

33 ± 16 for
borderline

51% female

By hip

33.9 ± 11.4

74.1%
female

By hip

LCEA Definition
of Dysplasia
Radiographic
Technique

Borderline
<25

By hip

Classic
N/A

20 -25

<20

Supine AP
pelvis

20 -25

Not included

Standing AP
pelvis

20 -24.9

<20

a
Data are shown as mean (range) or mean ± SD unless otherwise indicated. AP, anteroposterior; LCEA, lateral center-edge angle; LOE,
level of evidence; N/A, not available.

treated with arthroscopic surgery alone so were likely not
heavily represented in this study. Bolia et al7 reported a
retrospective comparative study of 2429 patients undergoing
arthroscopic FAI surgery. This study excluded subjects with
an LCEA <20 and >40 . Average age was 33 years, with
50.8% of the patients being women. The prevalence of borderline dysplasia was 12.6% in this population.

Borderline Versus Classic Acetabular Dysplasia
Most studies analyzed the prevalence of borderline dysplasia (LCEA, 20 -25 ) and acetabular dysplasia (LCEA, <20 )
to allow comparison (Table 4). In the general population
subgroup, the prevalence of borderline dysplasia was
higher than that of classic acetabular dysplasia in the general population group (3.5 times greater by subject, 20.4%
vs 5.9%; 4.4 times greater by hip, 19.4% vs. 4.4%) and in the

symptomatic population (1.3 times greater; 14.4% vs 11.3%
by hip) (Figure 3).

Male Versus Female Prevalence
In the general population subgroup, the prevalence of borderline dysplasia was slightly higher in women than men
(Table 5). By hip, the prevalence estimate was 23.7% for
women and 20.3% for men (Figure 4). By patient, the prevalence estimate was 20.6% for women and 17.9% for men.
The prevalence of classic acetabular dysplasia was similar
for men and women (men: mean, 4.5% [range, 2.4%-10.1%];
women: mean, 4.5% [range, 3.5%-20.6%]). Two studies in
the symptomatic group reported female versus male prevalence (Table 5). Matsuda et al36 reported that 65.4% (87/
133) of the patients with borderline dysplasia and acetabular dysplasia were women. The female prevalence was
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TABLE 4
Prevalence of Borderline and Classic Acetabular Dysplasia
Prevalence of Acetabular Dysplasia, % (n/N)
Studya
General population
Engesæter16
Raveendran47
Jacobsen22
Kapron27 (women only)
Pooled
Pooled
Targeted subpopulation
Harris20
Larson33
Kapron26
Symptomatic population
Kaya28
Kraeutler31
Pooled

Definition

Borderline

Classic

Ratio of Borderline:Classic Dysplasia

16.7 (346/2072)
25.1 (402/1601)
18.8 (601/3202)
19.2 (1480/7718)
46.0 (58/126)
20.4 (748/3673)
19.4 (2139/11,046)

3.3 (68/2072)
9.4 (150/1601)
5.9 (190/3202)
3.4 (266/7718)
20.6 (26/126)
5.9 (218/3673)
4.4 (482/11,046)

5:1
2:7
3:2
5:6
2:2
3:5
4:4

By patient
By hip
By hip

51.1 (24/47)
17.8 (21/118)
19.4 (26/134)

36.2 (17/47)
3.4 (4/118)
7.5 (10/134)

1:4
5:2
2:6

By hip
By hip
By hip

16.0 (16/100)
14.0 (54/386)
14.4 (70/486)

10.0 (10/100)
11.7 (45/386)
11.3 (55/486)

1:6
1:2
1:3

By
By
By
By
By
By
By

patient
patient
hip
hip
hip
patient
hip

a

Does not include studies that did not provide both borderline and classic dysplasia.

Figure 3. Prevalence of classic acetabular dysplasia. ES, effect size.

13.2% (87/659), and the male prevalence was 11.7% (46/
394). Bolia et al7 reported that 51% (155/305) of the patients
with borderline dysplasia were women. The female prevalence in this group was 13.9% (155/1114) in comparison
with 11.4% (150/1315) in men.

DISCUSSION
Borderline acetabular dysplasia remains a controversy in
the hip preservation field. Yet, even basic characteristics of
the condition, including the prevalence, have not been well

established in the literature. This study highlights how
commonly borderline dysplasia is present in the general
population and symptomatic groups. In this systematic
review, 11 studies used AP pelvic radiographs to measure
LCEA. These studies most commonly classified borderline
dysplasia as an LCEA of 20 to 25 and classic acetabular
dysplasia as an LCEA <20 . Four of the studies analyzed
the prevalence of borderline dysplasia in patients presenting with hip pain.7,28,31,36 Four studies16,22,27,47 analyzed
the prevalence of borderline dysplasia in the general population. The pooled estimate of the prevalence of borderline
dysplasia was 19.8% by patient and 23.3% by hip in the
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TABLE 5
Prevalence of Dysplasia in Male Versus Female Patientsa
Prevalence of Borderline Dysplasia, % (n/N)
Definition
General population
Engesæter16
Raveendran47
Jacobsen22
Kapron27
Targeted population
Harris20b
Kapron26
Symptomatic population
Matsuda36b
Bolia7

Prevalence of Classic Dysplasia, % (n/N)

Female

Male

Female

Male

18.7 (224/1199)
23.5 (221/939)
17.5 (329/1878)
18.6 (902/4860)
46.0 (58/126)

13.6 (119/873)
27.3 (181/662)
20.5 (272/1324)
20.2 (578/2858)
—

4.3 (52/1199)
8.8 (83/939)
6.0 (112/1878)
3.5 (171/4860)
20.6 (26/126)

2.4 (21/873)
10.1 (67/662)
5.9 (78/1324)
3.3 (95/2858)
—

By patient
By hip
By hip

96.2 (25/26)
92.3 (48/52)
—

81.0 (17/21)
73.8 (31/42)
19.4 (26/134)

—

—

—

7.5 (10/134)

By hip
By hip

13.2 (87/659)
13.9 (155/1114)

11.7 (46/394)
11.4 (150/1315)

—
—

—
—

By
By
By
By
By

patient
patient
hip
hip
hip

a

Studies that did not provide sex-specific prevalence data were excluded. -, not reported/not applicable.
Borderline þ classic dysplasia (LCEA, <25 ).

b

Figure 4. Prevalence of borderline acetabular dysplasia by sex. ES, effect size.
general population compared with 12.8% in symptomatic
patients. For comparison, the prevalence of acetabular
dysplasia was 4.6% by patient (6.7% by hip) in the general
population and 11.3% (by hip) in the symptomatic
population.
This study had several limitations. The published literature included patient data from varied populations and
demonstrated variability in the reported rates of borderline
dysplasia. While not all populations were equally represented in the analyzed studies, the combined analysis of
the available studies did provide more generalizable data
than a single study. In the symptomatic population studies,
only operatively treated patients were generally included.
This may have created significant selection bias. Particularly, in hip preservation, many surgeons only performed

some types of surgical procedures, which may have
excluded patients treated with other methods. While hip
arthroscopy is increasingly used as an adjunct treatment
in some hips with acetabular dysplasia undergoing PAO,
hips with classic acetabular dysplasia were likely underrepresented in these symptomatic cohorts, leading to
underestimation of the true prevalence of classic acetabular dysplasia.
Additionally, some studies calculated prevalence by
patient, and other studies calculated prevalence by hip.
In general, these studies did not provide detailed information to convert between these rates. In theory, if hips were
purely independent of each other, the prevalence by patient
would be double the prevalence by hip. However, given the
genetic and environmental effect on hip development, in
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the majority of individuals, hip morphology is relatively
similar. In theory, if this similarity were absolute, the prevalence by hip and by patient would be identical. Data from 1
population-based study that allowed conversion reported a
1.33 times higher prevalence by patient.47 However, given
the different characteristics of studies in each group, our
estimate for prevalence by hip was actually slightly higher
than the estimate by patient. If the 1.33 conversion factor
were used, the estimate of prevalence of 23.7% by hip would
represent a rate of 31.0% by patient. Thus, 19.8% to 31.0%
may represent the best overall estimate of prevalence by
patient. Given the potential inaccuracy of this conversion
factor, we chose to stratify the estimates by hip or by
patient as each study reported in actual data.
Systematic reviews enable comprehensive summary of
the literature to assess the available evidence regarding the
prevalence of borderline dysplasia in various populations.
This review has summarized the findings of each study.
The prevalence of borderline dysplasia was found to be
higher in the studies looking at the general population compared with the studies looking at symptomatic patients
(Figure 2). However, the prevalence of acetabular dysplasia
was higher in the symptomatic population than in the general population (Figure 3). This would be consistent with
classic acetabular dysplasia’s having an increased risk of
the development of symptoms compared with borderline
dysplasia. This is consistent with findings of Thomas
et al,52 who demonstrated the higher risk of OA in a setting
of classic acetabular dysplasia compared with borderline
acetabular dysplasia. This equates to a 1.4- to 2.0-times
elevated risk of OA in settings of borderline dysplasia compared with a 2.0- to 4.5-times elevated risk of OA from an
LCEA of 20 down to an LCEA of 0 .
Female sex is well recognized as a risk factor for acetabular dysplasia.14,15,34 Loder and Skopelja 34 found that
75.5% of the 9717 acetabular dysplasia cases were in
women. Tian et al53 found that the prevalence of acetabular
dysplasia was significantly higher among women than
men. These studies agree with our findings that in the general asymptomatic population, women had a higher prevalence of borderline dysplasia (Figure 4). However, in
borderline acetabular dysplasia, the difference between
women and men was relatively small.
This study demonstrated the high prevalence of borderline dysplasia in subjects presenting with prearthritic hip
pain (12.8%). The high proportion of subjects undergoing
hip preservation in the setting of borderline acetabular dysplasia underscored the importance of improving the evidence guiding treatment decisions in this common
population. Understanding the prevalence of borderline
dysplasia in the various patient populations may enable
surgeons to better understand the condition, its parameters, and suitable treatment options.

CONCLUSION
Using a systematic review of the literature and metaanalysis, this study demonstrated a prevalence of borderline dysplasia of 19.8% to 23.3% in the asymptomatic

The Orthopaedic Journal of Sports Medicine

general population. Additionally, an estimated prevalence
of 12.8% of hips in symptomatic patients highlighted the
common decision-making challenges in this population.
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APPENDIX
TABLE A1
Search Strings by Database
Ovid Medline (820 results)
(Exp hip/ OR (acetabular OR acetabulum OR hip OR femur OR femoral).mp.
AND (Wiberg.mp. OR “Lateral center edge angle”.mp. OR “Lateral centre edge angle”.mp. OR LCEA.mp. OR “Lateral central edge
angle”.mp. OR “Lateral central edge angles”.mp. OR “Lateral center edge angles”.mp. OR “LCE angle”.mp.))
OR
(Exp hip dislocation/ OR ((acetabular OR acetabulum OR hip) adj7 (luxation OR dislocation* OR displacement* OR dysplasia OR
dysplastic)).mp. OR femur head dislocation.mp. OR femur head dysplasia.mp. OR (Exp Developmental bone diseases/ AND hip.mp.) AND
(borderline.mp. OR border line.mp. OR (mild* adj2 (luxation OR dislocation* OR displacement* OR dysplasia OR dysplastic)).mp.))
Embase (1076 results)
((‘hip’/exp OR hip: ti, ab, kw, de OR acetabular: ti, ab, kw, de OR acetabulum: ti, ab, kw, de OR femur: ti, ab, kw, de OR femoral: ti, ab, kw, de)
AND (‘wiberg’: ti, ab, kw, de OR ‘Lateral center edge angle’: ti, ab, kw, de OR ‘Lateral center edge angles’: ti, ab, kw, de OR ‘Lateral central
edge angle’: ti, ab, kw, de OR ‘Lateral central edge angles’: ti, ab, kw, de OR ‘lateral centre edge angle’: ti, ab, kw, de OR ‘lateral centre edge
angles’: ti, ab, kw, de OR ‘LCE angle’: ti, ab, kw, de OR LCEA: ti, ab, kw, de))
OR
((‘hip dysplasia’/exp OR ((acetabular OR acetabulum OR hip) near/7 (luxation OR dislocation* OR displacement* OR dysplasia OR
dysplastic)): ti, ab, kw, de OR ‘femur head dislocation’: ti, ab, kw, de OR ‘femur head dysplasia’: ti, ab, kw, de OR ‘congenital hip disease’: ti,
ab, kw, de) AND (‘borderline’: ti, ab, kw, de OR ‘border line’: ti, ab, kw, de OR (mild* near/2 (luxation OR dislocation* OR displacement*
OR dysplasia OR dysplastic)): ti, ab, kw, de))
Cochrane Library:
Cochrane Database of Systematic Reviews (1 result)
Cochrane Central Register of Controlled Trials (33 results)
Database of Abstracts of Reviews of Effect (0 results)
1. [mh hip] OR hip: ti, ab, kw OR acetabular: ti, ab, kw OR acetabulum: ti, ab, kw OR femur: ti, ab, kw OR femoral: ti, ab, kw
2. “wiberg”: ti, ab, kw OR “Lateral center edge angle”: ti, ab, kw OR “Lateral center edge angles”: ti, ab, kw OR “Lateral central edge angle”:
ti, ab, kw OR “Lateral central edge angles”: ti, ab, kw OR “lateral centre edge angle”: ti, ab, kw OR “lateral centre edge angles”: ti, ab, kw
OR “LCE angle”: ti, ab, kw OR LCEA: ti, ab, kw
3. #1 AND #2
4. [mh “hip dislocation”] OR ((acetabular OR acetabulum OR hip) near/7 (luxation OR dislocation* OR displacement* OR dysplasia OR
dysplastic)): ti, ab, kw OR femur head dislocation: ti, ab, kw OR femur head dysplasia: ti, ab, kw OR ([mh “Developmental bone
diseases”] AND hip: ti, ab, kw)
5. borderline: ti, ab, kw OR “border line”: ti, ab, kw OR (mild* near/2 (luxation OR dislocation* OR displacement* OR dysplasia OR
dysplastic)): ti, ab, kw
6. #4 AND #5
7. #3 OR #6
Clinicaltrials.gov (0 results)
Borderline hip dysplasia

